Premium
Olanzapine efficacy in the treatment of essential tremor
Author(s) -
Yetimalar Y.,
Irtman G.,
Gürgör N.,
Başoğlu M.
Publication year - 2003
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1046/j.1468-1331.2003.00534.x
Subject(s) - olanzapine , medicine , essential tremor , clinical trial , clinical efficacy , open label , pharmacology , psychiatry , schizophrenia (object oriented programming)
We investigated the anti‐tremor effect of olanzapine, a novel atypical antidopaminergic drug, in 37 patients with essential tremor (ET) in an open‐label and prospective study by clinical scoring and patient self‐evaluation. Olanzapine monotherapy appears to be efficacious for the treatment of ET. Further clinical trials with control groups are indicated to establish the efficacy of olanzapine in patients with ET.